Back to results
US 7,402,598 B2Granted
Arylethanolamine β2-adrenoreceptor agonist compounds
AssigneeGlaxo Group Limited
InventorsKeith Biggadike, Diane Mary Coe, Duncan Stuart Holmes, Brian Edgar Looker
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds of formula (I) as defined herein and salts or solvates thereof. Processes for preparing these compounds and pharmaceutical formulations containing them are also disclosed, as well as methods for the prophylaxis of treatment of a clinical condition using such compounds.
Claims25
A compound of formula (I)
- or a salt thereof, wherein:
- n is an integer of from 2 to 8;
- m is an integer of from 3 to 11, with the proviso that the sum of n+m is from 5 to 19;
- R1 is —XSO2NR6R7;
- wherein X is —(CH2)p- or C2-6 alkenylene;
- p is an integer from 0 to 6;
- R6 and R7 are independently selected from hydrogen, C1-6alkyl, C3-7cycloalkyl, CONR8R9, phenyl and phenyl(C1-4alkyl)-,
- or R6 and R7, together with the nitrogen atom to which they are bonded, form a 5-, 6- or 7- membered nitrogen containing ring;
- and R6 and R7 are each independently optionally substituted by 1 or 2 groups independently selected from halo, C1-6alkyl, C1-6alkoxy, hydroxy-substituted C1-6alkoxy,
- C1-6haloalkyl, CO2R8, SO2R8R9, —CONR8R9, —NR8C(O)R9 or a 5-, 6- or 7-membered heterocyclic ring;
- R8 and R9 are independently selected from hydrogen, C1-6alkyl, C3-7cycloalkyl, phenyl and phenyl(C1-6alkyl)-;
- R2 and R3 are independently selected from hydrogen, C1-6alkyl, C1-6alkoxy, halo, phenyl and C1-6haloalkyl;
- R4 and R5 are independently selected from hydrogen and C1-4 alkyl with the proviso that the total number of carbon atoms in R4 and R5 is not more than 4, and
- Ar is a group selected from the group consisting of:
- wherein R11 represents hydrogen, halogen, —(CH2)qOR14, —NR14C(O)R15, —NR14SO2R15,
- —SO2NR14R15, —NR14R15, —OC(O)R16 or OC(O)NR14R15, and R10 represents hydrogen, halogen or C1-4 alkyl;
- or R11 represents —NHR17 and R10 and —NHR17 together form a 5- or 6-membered heterocyclic ring;
- R12 represents hydrogen, halogen, —OR14 or —NR14R15;—OC(O)R16 or —OC(O)NR14R15;
- R13 represents hydrogen, halogen, haloC1-4 alkyl, —OR14 or —NR14 R15;
- R14 and R15 each independently represents hydrogen or C1-4 alkyl, or in the groups
- —NR14R15, —SO2NR14R15 and —OC(O)NR14R15, R14 and R15 independently represent hydrogen or C1-4 alkyl or together with the nitrogen atom to which they are attached form a 5-, 6- or 7-membered nitrogen-containing ring,
- R16 represents an aryl group which may be unsubstituted or substituted by one or more substituents selected from halogen, C1-4 alkyl, hydroxy, C1-4 alkoxy or halo C1-4 alkyl;
- and
- q is zero or an integer from 1 to 4;
- provided that Ar is not a group (a) wherein R11 is (CH2)qOR14 or NR14COR15, and R12 is OR14.
22 more elements
A compound selected from the group consisting of:
- 8-Hydroxy-5-((1R)-1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)quinolin-2(1H)-one;
- 3-{4-[(6-{[(2R)-2-Hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl]amino}hexyl)oxy]butyl}benzenesulfonamide;
- 5-Hydroxy-8-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)-2H-1,4-benzoxazin-3(4H)-one;
- 3-{4-[(6-{[2-hydroxy-2-(5-hydroxy-3-oxo-3,4-dihydro-2H- 1,4-benzoxazin-8-yl)ethyl]amino}hexyl)oxy]butyl}benzenesulfonamide;
- 4-Hydroxy-7-((1R)-1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)-1,3-benzothiazol-2(3H)-one;
- 4-Hydroxy-7-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)-1,3-benzothiazol-2(3H)-one;
- 3-{4-[(6-{[(2R)-2-(3-Fluoro-4-hydroxyphenyl)-2-hydroxyethyl]amino}hexyl)oxy]butyl}benzenesulfonamide;
- 3-(4-{[6-({2-Hydroxy-2-[5-hydroxy-6-(hydroxymethyl)pyridin-2-yl]ethyl}amino)hexyl]oxy}butyl)benzenesulfonamide;
- 3-[4-({6-[((2R)-2-Hydroxy-2-{4-hydroxy-3-[(methylsulfonyl)amino]phenyl}ethyl)amino]hexyl}oxy)butyl]benzenesulfonamide;
- 3-{3-[(7-{[(2R)-2-(3-Fluoro-4-hydroxyphenyl )-2-hydroxyethyl]amino}heptyl)oxy]propyl}benzenesulfonamide;
- 3-(3-{[7-({2-Hydroxy-2-[5-hydroxy-6-(hydroxymethyl )pyridin-2-yl]ethyl}amino)heptyl]oxy}propyl)benzenesulfonamide;
- 3-[3-({7-[((2R)-2-Hydroxy-2-{4-hydroxy-3-[(methylsulfonyl)amino]phenyl}ethyl)amino]heptyl}oxy)propyl]benzenesulfonamide;
- 3-{3-[(7-{[(2R)-2-Hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl]amino}heptyl)oxy]propyl}benzenesulfonamide;
- 3-(3-{[7-({(2R)-2-[3-(Formylamino)-4-hydroxyphenyl]-2-hydroxyethyl}amino)heptyl]oxy}propyl)benzenesulfonamide;
- and a salt thereof.
12 more elements
Dependencies are inferred from the claim text.